>
Switch to:

Instil Bio EV-to-EBITDA

: -33.05 (As of Today)
View and export this data going back to 2021. Start your Free Trial

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Instil Bio's enterprise value is $1,906.79 Mil. Instil Bio's EBITDA for the trailing twelve months (TTM) ended in Jun. 2021 was $-57.69 Mil. Therefore, Instil Bio's EV-to-EBITDA for today is -33.05.

The historical rank and industry rank for Instil Bio's EV-to-EBITDA or its related term are showing as below:

NAS:TIL' s EV-to-EBITDA Range Over the Past 10 Years
Min: -33.05   Med: -1.69   Max: 2.65
Current: -32.61

-33.05
2.65

During the past 2 years, the highest EV-to-EBITDA of Instil Bio was 2.65. The lowest was -33.05. And the median was -1.69.

NAS:TIL's EV-to-EBITDA is ranked lower than
99.99% of the 37 Companies
in the Biotechnology industry.

( Industry Median: 17.53 vs. NAS:TIL: -32.61 )

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2021-10-28), Instil Bio's stock price is $19.03. Instil Bio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2021 was $. Therefore, Instil Bio's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Instil Bio EV-to-EBITDA Historical Data

The historical data trend for Instil Bio's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Instil Bio Annual Data
Trend Dec19 Dec20
EV-to-EBITDA
- -

Instil Bio Quarterly Data
Dec19 Mar20 Jun20 Dec20 Mar21 Jun21
EV-to-EBITDA Premium Member Only - - - -95.17 -33.29

Competitive Comparison

For the Biotechnology subindustry, Instil Bio's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Instil Bio EV-to-EBITDA Distribution

For the Biotechnology industry and Healthcare sector, Instil Bio's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Instil Bio's EV-to-EBITDA falls into.



Instil Bio EV-to-EBITDA Calculation

Instil Bio's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=1906.791/-57.689
=-33.05

Instil Bio's current Enterprise Value is $1,906.79 Mil.
Instil Bio's EBITDA for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $-57.69 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Instil Bio  (NAS:TIL) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Instil Bio's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=19.03/-0.930
=At Loss

Instil Bio's share price for today is $19.03.
Instil Bio's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Instil Bio EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Instil Bio's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Instil Bio Business Description

Instil Bio logo
Industry
Healthcare » Biotechnology NAICS : 325412 SIC : 2834
Comparable Companies
Traded in Other Exchanges
N/A
Address
3963 Maple Avenue, Suite 350, Dallas, TX, USA, 75219
Instil Bio Inc is a clinical-stage cell therapy company. It is developing tumor infiltrating lymphocytes for the treatment of cancer.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)